Clinical Trial Update: A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route [Phase 1]

View source ↗

Summary

Phase 1 trial assessing abuse potential and safety of CL-108 tablets in opioid-experienced, non-dependent recreational drug users; completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea
• Pain
• Vomiting

Drugs mentioned

• CL-108 tablets

Snippet

Sponsor: Charleston Laboratories, Inc | Conditions: Pain, Nausea | Phase 1 | Status: COMPLETED | Results posted: 2019-10-14